NEXENTIS TECHNOLOGIES INC. Depreciation
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Depreciation of $1.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-31
- NEXENTIS TECHNOLOGIES INC. depreciation for fiscal 2025 was $1.00K, a 94.44% decline from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. depreciation for fiscal 2024 was $18.00K, a 14.29% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. depreciation for fiscal 2023 was $21.00K, a 61.62% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. depreciation for fiscal 2022 was $54.72K, a 148.73% increase from fiscal 2021.
| Period end | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $18.00K 10-K · filed 2025-03-31 | |
| 2023-12-31 | $21.00K 10-K · filed 2025-03-31 | $20.84K 10-K · filed 2024-04-01 |
| 2022-12-31 | $54.72K 10-K · filed 2024-04-01 | |
| 2021-12-31 | $22.00K 10-K · filed 2023-03-27 | |
| 2020-12-31 | $22.51K 10-K · filed 2022-03-31 | |
| 2019-12-31 | $27.35K 10-K · filed 2021-03-29 | |
| 2018-12-31 | $38.89K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |